JPWO2019211434A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019211434A5
JPWO2019211434A5 JP2020561763A JP2020561763A JPWO2019211434A5 JP WO2019211434 A5 JPWO2019211434 A5 JP WO2019211434A5 JP 2020561763 A JP2020561763 A JP 2020561763A JP 2020561763 A JP2020561763 A JP 2020561763A JP WO2019211434 A5 JPWO2019211434 A5 JP WO2019211434A5
Authority
JP
Japan
Prior art keywords
group
compound
formula
pharmaceutical
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020561763A
Other languages
English (en)
Japanese (ja)
Other versions
JP7307498B2 (ja
JP2021522301A (ja
Publication date
Priority claimed from EP18382306.1A external-priority patent/EP3564211A1/en
Application filed filed Critical
Publication of JP2021522301A publication Critical patent/JP2021522301A/ja
Publication of JPWO2019211434A5 publication Critical patent/JPWO2019211434A5/ja
Application granted granted Critical
Publication of JP7307498B2 publication Critical patent/JP7307498B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561763A 2018-05-03 2019-05-03 ジペプチジルケトアミドメタ-メトキシフェニル誘導体およびその使用 Active JP7307498B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382306.1A EP3564211A1 (en) 2018-05-03 2018-05-03 Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof
EP18382306.1 2018-05-03
PCT/EP2019/061369 WO2019211434A1 (en) 2018-05-03 2019-05-03 Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2021522301A JP2021522301A (ja) 2021-08-30
JPWO2019211434A5 true JPWO2019211434A5 (es) 2022-01-12
JP7307498B2 JP7307498B2 (ja) 2023-07-12

Family

ID=62222549

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561763A Active JP7307498B2 (ja) 2018-05-03 2019-05-03 ジペプチジルケトアミドメタ-メトキシフェニル誘導体およびその使用

Country Status (12)

Country Link
US (1) US11242312B2 (es)
EP (2) EP3564211A1 (es)
JP (1) JP7307498B2 (es)
CN (1) CN112368263B (es)
AU (1) AU2019263953B2 (es)
BR (1) BR112020022364B1 (es)
CA (1) CA3100188A1 (es)
ES (1) ES2964159T3 (es)
HU (1) HUE064420T2 (es)
MX (1) MX2020011700A (es)
PL (1) PL3788031T3 (es)
WO (1) WO2019211434A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686335B1 (en) * 1998-09-22 2004-02-03 Cephalon, Inc. Hydroxamate-containing cysteine and serine protease inhibitors
EP1454627A1 (en) 2003-03-06 2004-09-08 MyoContract Ltd. Alpha-Keto carbonyl calpain inhibitors
ATE446948T1 (de) 2003-12-12 2009-11-15 Senju Pharma Co Alpha-ketoamidderivativ, herstellungsverfahren und verwendung davon
GB2467562A (en) * 2009-02-06 2010-08-11 Summit Corp Plc Dual calpain-ROS inhibitors
WO2012021788A2 (en) * 2010-08-13 2012-02-16 Banyan Biomarkers Dipeptide calpain inhibitors
ES2731274T3 (es) * 2014-09-08 2019-11-14 Landsteiner Genmed S L Compuestos de dipeptidil-cetoamida y su uso para el tratamiento y/o la prevención de la acumulación de grasa
WO2017156074A1 (en) 2016-03-09 2017-09-14 Blade Therapeutics, Inc. Calpain modulators and methods of production and use thereof

Similar Documents

Publication Publication Date Title
JP2021138755A5 (es)
JP2020502047A5 (es)
JP2018513150A5 (es)
JP2017504642A5 (es)
JP2015522616A5 (es)
JP2019524883A5 (es)
JP2010532768A5 (es)
JP2020097596A5 (es)
JP2006514012A5 (es)
JP2008536833A5 (es)
JP2006511587A5 (es)
JP2012526766A5 (es)
JP2018135343A5 (es)
JP2013502441A5 (es)
JP2013526497A5 (es)
JP2015527355A5 (es)
JP2020505354A5 (es)
JP2013544797A5 (es)
JP2005538051A5 (es)
JP2020532545A5 (es)
JP2015508068A5 (es)
JP2018535235A5 (es)
JP2019536778A5 (es)
JPWO2019211434A5 (es)
JP2021191784A5 (es)